A citation-based method for searching scientific literature

Rory M Shallis, Amer M Zeidan, Rong Wang, Nikolai A Podoltsev. Hematol Oncol Clin North Am 2021
Times Cited: 6







List of co-cited articles
29 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Epidemiology of the classical myeloproliferative neoplasms: The four corners of an expansive and complex map.
Rory M Shallis, Rong Wang, Amy Davidoff, Xiaomei Ma, Nikolai A Podoltsev, Amer M Zeidan. Blood Rev 2020
37
50

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.
Daniel A Arber, Attilio Orazi, Robert Hasserjian, Jürgen Thiele, Michael J Borowitz, Michelle M Le Beau, Clara D Bloomfield, Mario Cazzola, James W Vardiman. Blood 2016
50

A gain-of-function mutation of JAK2 in myeloproliferative disorders.
Robert Kralovics, Francesco Passamonti, Andreas S Buser, Soon-Siong Teo, Ralph Tiedt, Jakob R Passweg, Andre Tichelli, Mario Cazzola, Radek C Skoda. N Engl J Med 2005
50

The impact of myeloproliferative neoplasms (MPNs) on patient quality of life and productivity: results from the international MPN Landmark survey.
Claire N Harrison, Steffen Koschmieder, Lynda Foltz, Paola Guglielmelli, Tina Flindt, Michael Koehler, Jonathan Mathias, Norio Komatsu, Robert N Boothroyd, Amber Spierer,[...]. Ann Hematol 2017
58
33

Inherited predisposition to myeloproliferative neoplasms.
Amy V Jones, Nicholas C P Cross. Ther Adv Hematol 2013
40
33

Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study.
A Tefferi, E Rumi, G Finazzi, H Gisslinger, A M Vannucchi, F Rodeghiero, M L Randi, R Vaidya, M Cazzola, A Rambaldi,[...]. Leukemia 2013
399
33

The Microenvironment in Myeloproliferative Neoplasms.
Gajalakshmi Ramanathan, Angela G Fleischman. Hematol Oncol Clin North Am 2021
7
33

Familial MPN Predisposition.
Tsewang Tashi, Sabina Swierczek, Josef T Prchal. Curr Hematol Malig Rep 2017
13
33

Myeloproliferative neoplasms: trends in incidence, prevalence and survival in Norway.
Christina Roaldsnes, René Holst, Henrik Frederiksen, Waleed Ghanima. Eur J Haematol 2017
26
33

Aetiology of Myeloproliferative Neoplasms.
Mary Frances McMullin, Lesley Ann Anderson. Cancers (Basel) 2020
6
33

Changing incidence of myeloproliferative neoplasms in Australia, 2003-2014.
Peter D Baade, David M Ross, Lesley A Anderson, Cecily Forsyth, Lin Fritschi. Am J Hematol 2019
12
33

Inflammatory Pathophysiology as a Contributor to Myeloproliferative Neoplasms.
Daniel Arthur Corpuz Fisher, Jared Scott Fowles, Amy Zhou, Stephen Tracy Oh. Front Immunol 2021
25
33

Somatic mutations of calreticulin in myeloproliferative neoplasms.
Thorsten Klampfl, Heinz Gisslinger, Ashot S Harutyunyan, Harini Nivarthi, Elisa Rumi, Jelena D Milosevic, Nicole C C Them, Tiina Berg, Bettina Gisslinger, Daniela Pietra,[...]. N Engl J Med 2013
33

Inflammatory Microenvironment and Specific T Cells in Myeloproliferative Neoplasms: Immunopathogenesis and Novel Immunotherapies.
Vincenzo Nasillo, Giovanni Riva, Ambra Paolini, Fabio Forghieri, Luca Roncati, Beatrice Lusenti, Monica Maccaferri, Andrea Messerotti, Valeria Pioli, Andrea Gilioli,[...]. Int J Mol Sci 2021
10
33


Genetics and Pathogenetic Role of Inflammasomes in Philadelphia Negative Chronic Myeloproliferative Neoplasms: A Narrative Review.
Valeria Di Battista, Maria Teresa Bochicchio, Giulio Giordano, Mariasanta Napolitano, Alessandro Lucchesi. Int J Mol Sci 2021
14
33

Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2.
J Nangalia, C E Massie, E J Baxter, F L Nice, G Gundem, D C Wedge, E Avezov, J Li, K Kollmann, D G Kent,[...]. N Engl J Med 2013
33

MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients.
Animesh D Pardanani, Ross L Levine, Terra Lasho, Yana Pikman, Ruben A Mesa, Martha Wadleigh, David P Steensma, Michelle A Elliott, Alexandra P Wolanskyj, William J Hogan,[...]. Blood 2006
768
33

Myeloproliferative neoplasm stem cells.
Adam J Mead, Ann Mullally. Blood 2017
87
33

An immune dysregulation in MPN.
Giovanni Barosi. Curr Hematol Malig Rep 2014
60
33

The Essential Thrombocythemia in 2020: What We Know and Where We Still Have to Dig Deep.
Vincenzo Accurso, Marco Santoro, Salvatrice Mancuso, Mariasanta Napolitano, Melania Carlisi, Marta Mattana, Chiara Russo, Alessandro Di Stefano, Davide Sirocchi, Sergio Siragusa. Clin Med Insights Blood Disord 2020
12
33

The germline sequence variant rs2736100_C in TERT associates with myeloproliferative neoplasms.
A Oddsson, S Y Kristinsson, H Helgason, D F Gudbjartsson, G Masson, A Sigurdsson, A Jonasdottir, A Jonasdottir, H Steingrimsdottir, B Vidarsson,[...]. Leukemia 2014
73
33


A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms.
Damla Olcaydu, Ashot Harutyunyan, Roland Jäger, Tiina Berg, Bettina Gisslinger, Ingrid Pabinger, Heinz Gisslinger, Robert Kralovics. Nat Genet 2009
271
33

Common germline variation at the TERT locus contributes to familial clustering of myeloproliferative neoplasms.
Roland Jäger, Ashot S Harutyunyan, Elisa Rumi, Daniela Pietra, Tiina Berg, Damla Olcaydu, Richard S Houlston, Mario Cazzola, Robert Kralovics. Am J Hematol 2014
40
33


Risk of Inflammatory Bowel Disease in Patients with Chronic Myeloproliferative Neoplasms: A Danish Nationwide Cohort Study.
Marie Bak, Tine Jess, Esben Meulengracht Flachs, Ann-Dorthe Zwisler, Knud Juel, Henrik Frederiksen. Cancers (Basel) 2020
3
66

Myeloproliferative Neoplasms.
Jerry L Spivak. N Engl J Med 2017
195
33

Ethnic differences in acute promyelocytic leukaemia between New Zealand Polynesian and European patients.
Chris Varghese, Valery Yizhuo Liu, Tracey Immanuel, Nicole Chien, Taryn Green, George Chan, Edward Theakston, Maggie Kalev-Zylinska. Hematology 2021
2
50

Ethnicity and body fatness in New Zealanders.
Elizabeth Duncan, Grant Schofield, Scott Duncan, Gregory Kolt, Elaine Rush. N Z Med J 2004
14
16

Reporting of race and ethnicity at an international haematology conference.
Ansh Mehta, Nathanael Fillmore, Saurabh Dahiya, Anita D'Souza, John Sweetenham, Ankit Kansagra. Br J Haematol 2020
3
33

Unique features of primary myelofibrosis in Chinese.
Zefeng Xu, Robert Peter Gale, Yue Zhang, Tiejun Qin, Huishu Chen, Peihong Zhang, Tianjiao Zhang, Liu Liu, Shiqiang Qu, Zhijian Xiao. Blood 2012
30
16

Ethnic and socioeconomic disparities in the prevalence of cardiovascular disease in New Zealand.
Wing Cheuk Chan, Craig Wright, Tania Riddell, Susan Wells, Andrew J Kerr, Geeta Gala, Rod Jackson. N Z Med J 2008
51
16

External validation and clinical evaluation of the International Prognostic Score of Thrombosis for Essential Thrombocythemia (IPSET-thrombosis) in a large cohort of Chinese patients.
Rongfeng Fu, Min Xuan, Cuicui Lv, Liyan Zhang, Huiyuan Li, Xian Zhang, Donglei Zhang, Tiantian Sun, Feng Xue, Xiaofan Liu,[...]. Eur J Haematol 2014
18
16

Distinctive features of polycythaemia vera in New Zealand Polynesians.
Merit Z Hanna, Maggie L Kalev-Zylinska, Sharon R Jackson, Gordon Royle, Hilary A Blacklock. N Z Med J 2018
1
100

Epidemiology of myelofibrosis, essential thrombocythemia, and polycythemia vera in the European Union.
Odile Moulard, Jyotsna Mehta, Jon Fryzek, Robert Olivares, Usman Iqbal, Ruben A Mesa. Eur J Haematol 2014
122
16

Incidence and risk factors for myelofibrotic transformation among 272 Chinese patients with JAK2-mutated polycythemia vera.
Jie Bai, Limei Ai, Lei Zhang, Feng-Chun Yang, Yuan Zhou, Yanping Xue. Am J Hematol 2015
9
16

DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status.
Naseema Gangat, Domenica Caramazza, Rakhee Vaidya, Geeta George, Kebede Begna, Susan Schwager, Daniel Van Dyke, Curtis Hanson, Wenting Wu, Animesh Pardanani,[...]. J Clin Oncol 2011
640
16

Cancer disparities in indigenous Polynesian populations: Māori, Native Hawaiians, and Pacific people.
Gabi U Dachs, Margaret J Currie, Fiona McKenzie, Mona Jeffreys, Brian Cox, Sunia Foliaki, Loïc Le Marchand, Bridget A Robinson. Lancet Oncol 2008
61
16

Incidence of myeloproliferative neoplasms in Calgary, Alberta, Canada.
Jonathan Heppner, Leonard Tu Nguyen, Maggie Guo, Christopher Naugler, Fariborz Rashid-Kolvear. BMC Res Notes 2019
6
16

Modifiable Lifestyle and Medical Risk Factors Associated With Myeloproliferative Neoplasms.
Andrew S Duncombe, Lesley A Anderson, Glen James, Frank de Vocht, Lin Fritschi, Ruben Mesa, Mike Clarke, Mary Frances McMullin. Hemasphere 2020
13
16

Racial and ethnic disparities in hematologic malignancies.
Kedar Kirtane, Stephanie J Lee. Blood 2017
74
16

New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment.
Francisco Cervantes, Brigitte Dupriez, Arturo Pereira, Francesco Passamonti, John T Reilly, Enrica Morra, Alessandro M Vannucchi, Ruben A Mesa, Jean-Loup Demory, Giovanni Barosi,[...]. Blood 2009
848
16

E-cadherin germline mutations in familial gastric cancer.
P Guilford, J Hopkins, J Harraway, M McLeod, N McLeod, P Harawira, H Taite, R Scoular, A Miller, A E Reeve. Nature 1998
16

Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia.
Francesco Passamonti, Elisa Rumi, Ester Pungolino, Lucia Malabarba, Paola Bertazzoni, Marina Valentini, Ester Orlandi, Luca Arcaini, Ercole Brusamolino, Cristiana Pascutto,[...]. Am J Med 2004
311
16

Sex determines the presentation and outcomes in MPN and is related to sex-specific differences in the mutational burden.
Theodoros Karantanos, Shruti Chaturvedi, Evan M Braunstein, Jerry Spivak, Linda Resar, Styliani Karanika, Donna M Williams, Ophelia Rogers, Christopher D Gocke, Alison R Moliterno. Blood Adv 2020
25
16

Lifestyle factors and risk of myeloproliferative neoplasms in the NIH-AARP diet and health study.
Nikolai A Podoltsev, Xiaoyi Wang, Rong Wang, Jonathan N Hofmann, Linda M Liao, Amer M Zeidan, Ruben Mesa, Xiaomei Ma. Int J Cancer 2020
9
16

Gender and survival in essential thrombocythemia: A two-center study of 1,494 patients.
Ayalew Tefferi, Silvia Betti, Daniela Barraco, Mythri Mudireddy, Sahrish Shah, Curtis A Hanson, Rhett P Ketterling, Animesh Pardanani, Naseema Gangat, Giacomo Coltro,[...]. Am J Hematol 2017
20
16

Cancer survival in New Zealand: ethnic, social and geographical inequalities.
Robin Haynes, Jamie Pearce, Ross Barnett. Soc Sci Med 2008
81
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.